You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 3626 to 3650 of about 6093
Next 25
10/21/2008
The second annual FRED COHEN MEMORIAL SYMPOSIUM "Managing Life with a Brain Tumor: A Practical Approach for Patients & Families"
10/19/2008
Temozolomide for high grade glioma.
High-grade glioma before and after treatment with radiation and Avastin: Initial observations
HR 7153: The National Childhood Brain Tumor Prevention Network Act
IBTA E-NEWSLETTER 15 October 2008
Lithium inhibits invasion of glioma cells; possible involvement of glycogen synthase kinase-3
Local tennis: Swingtime announces Super Bowl tickets drawing
10/17/2008
Swedish in Seattle Unveils State-of-the-Art Brain Tumor Center Combining Advanced Treatment With Innovation in Research
The chances of developing a malignant tumour are “significantly increased” for people who use a mobile for ten years.
Experience with irinotecan for the treatment of malignant glioma
Sagopilone crosses the blood-brain barrier in vivo to inhibit brain tumor growth and metastases
Monmouth Medical Center art exhibit features original artwork created by kids and teens affected by a loved one’s brain tumor
10/09/2008
Free tickets to NY Islanders and Virtualtrials.com is moving!
10/08/2008
Target Acquired: It may become possible to vaccinate against brain tumours
10/06/2008
Urbana quilt project raises money for brain cancer research
UCSF surgeon changes study of brain tumors
10/04/2008
Proton Radiation Appears to Lower Risk for Secondary Cancers
Efficacy of a phase II vaccine targeting Cytomegalovirus antigens in newly diagnosed GBM.
Prospective phase II trial for recurrent high-grade gliomas with capacitive coupled low radiofrequency (LRF) hyperthermia.
A phase II trial with cetuximab, bevacizumab, and irinotecan for patients with primary glioblastomas and progression after radiation therapy and temozolamide.
Phase I/II study of cetuximab plus temozolomide as radiochemotherapy for primary glioblastoma (GERT)
Role of a second chemotherapy in recurrent malignant glioma patients who progress on a bevacizumab-containing regimen.
A phase II, randomized, non-comparative clinical trial of the effect of bevacizumab (BV) alone or in combination with irinotecan (CPT) on 6-month progression free survival (PFS6) in recurrent, treatment-refractory glioblastoma (GBM).
Effect of EGFRvIII-targeted vaccine (CDX-110) on immune response and TTP when given with simultaneous standard and continuous temozolomide in patients with GBM.
Phase II trial of talampanel in conjunction with standard radiation (RT) and temozolomide (TMZ) in patients with newly diagnosed glioblastoma (GBM).